IS7300A - Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi - Google Patents

Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi

Info

Publication number: IS7300A
Authority: IS; Iceland
Prior art keywords: breast cancer; anastrozole; early; postmenopausal women; stage breast
Prior art date: 2001-12-10

Application number

IS7300A

Other languages

English (en)

Inventor

Plourde Paul

Rogers Anthony

Vose Brent

Dukes Michael

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-10

Filing date

2004-06-04

Publication date

2004-06-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9927290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-04 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-06-04 Publication of IS7300A publication Critical patent/IS7300A/is

Links

206010006187 Breast cancer Diseases 0.000 title abstract 3
208000026310 Breast neoplasm Diseases 0.000 title abstract 3
YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 title abstract 2
229960002932 anastrozole Drugs 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Chemical Treatment Of Metals (AREA)

IS7300A 2001-12-10 2004-06-04 Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi IS7300A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0129457.8A GB0129457D0 (en)	2001-12-10	2001-12-10	Method of treatment
PCT/GB2002/005554 WO2003053438A1 (en)	2001-12-10	2002-12-06	Use of anastrozole for the treatment of post-menopausal women having early breast cancer

Publications (1)

Publication Number	Publication Date
IS7300A true IS7300A (is)	2004-06-04

Family

ID=9927290

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7300A IS7300A (is)	2001-12-10	2004-06-04	Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi

Country Status (28)

Country	Link
US (1)	US20050165081A1 (is)
EP (2)	EP1997492A1 (is)
JP (2)	JP5335173B2 (is)
KR (1)	KR100858946B1 (is)
CN (1)	CN100408036C (is)
AT (1)	ATE406160T1 (is)
AU (1)	AU2002347371B2 (is)
BR (1)	BR0214798A (is)
CA (1)	CA2468965C (is)
CO (1)	CO5590926A2 (is)
CY (1)	CY1108462T1 (is)
DE (1)	DE60228616D1 (is)
DK (1)	DK1455781T3 (is)
ES (1)	ES2303811T3 (is)
GB (1)	GB0129457D0 (is)
HU (1)	HUP0402023A3 (is)
IL (1)	IL162150A0 (is)
IS (1)	IS7300A (is)
MX (1)	MXPA04005394A (is)
NO (1)	NO20042912L (is)
NZ (1)	NZ533106A (is)
PL (1)	PL369411A1 (is)
PT (1)	PT1455781E (is)
RU (1)	RU2320339C2 (is)
SI (1)	SI1455781T1 (is)
UA (1)	UA79443C2 (is)
WO (1)	WO2003053438A1 (is)
ZA (1)	ZA200404260B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0129457D0 (en) *	2001-12-10	2002-01-30	Astrazeneca Ab	Method of treatment
US8436029B2 (en) *	2004-03-19	2013-05-07	Transform Pharmaceuticals, Inc.	Pharmaceutical forms, and methods of making and using the same
WO2005117864A1 (en) *	2004-05-28	2005-12-15	Astrazeneca Ab	Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN100337625C (zh) *	2004-08-30	2007-09-19	鲁南制药集团股份有限公司	阿那曲唑的分散片剂型
CN1304054C (zh) *	2004-12-29	2007-03-14	山东蓝金生物工程有限公司	一种缓慢释放的抗癌药物组合物
GB0517673D0 (en) *	2005-08-31	2005-10-05	Astrazeneca Ab	Formulation
GB0517674D0 (en) *	2005-08-31	2005-10-05	Astrazeneca Ab	Formulation
WO2011130381A1 (en) *	2010-04-13	2011-10-20	Estrocept Diagnostics, Inc.	Diagnostic assays for breast cancer treatment and progression
US10201549B2 (en)	2013-06-14	2019-02-12	Professional Compounding Centers Of America (Pcca)	Testosterone combined with anastrozole injection solutions
CN103450099B (zh) *	2013-09-06	2015-03-25	杭州华东医药集团新药研究院有限公司	阿那曲唑及其一水合物的新晶型、制备和用途
RU2548722C1 (ru) *	2013-12-06	2015-04-20	Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт"	Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола
DE102014005513B4 (de) *	2014-04-15	2018-03-15	Sanoxsys Gmbh	Mittel zur Prävention und Therapie von Tumorerkrankungen
KR20250152679A (ko)	2015-04-29	2025-10-23	래디어스 파마슈티컬스, 인코포레이티드	암을 치료하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8714013D0 (en) *	1987-06-16	1987-07-22	Ici Plc	(substituted-aralkyl)heterocyclic compounds
AR034142A1 (es) *	2000-09-08	2004-02-04	Sloan Kettering Inst Cancer	Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
GB0129457D0 (en) *	2001-12-10	2002-01-30	Astrazeneca Ab	Method of treatment

2001
- 2001-12-10 GB GBGB0129457.8A patent/GB0129457D0/en not_active Ceased
2002
- 2002-06-12 UA UA20040705521A patent/UA79443C2/uk unknown
- 2002-12-06 AT AT02783305T patent/ATE406160T1/de active
- 2002-12-06 HU HU0402023A patent/HUP0402023A3/hu not_active Application Discontinuation
- 2002-12-06 RU RU2004121162/15A patent/RU2320339C2/ru not_active IP Right Cessation
- 2002-12-06 NZ NZ533106A patent/NZ533106A/xx not_active IP Right Cessation
- 2002-12-06 JP JP2003554195A patent/JP5335173B2/ja not_active Expired - Lifetime
- 2002-12-06 CA CA2468965A patent/CA2468965C/en not_active Expired - Fee Related
- 2002-12-06 ES ES02783305T patent/ES2303811T3/es not_active Expired - Lifetime
- 2002-12-06 CN CNB02824544XA patent/CN100408036C/zh not_active Ceased
- 2002-12-06 AU AU2002347371A patent/AU2002347371B2/en not_active Revoked
- 2002-12-06 KR KR1020047008806A patent/KR100858946B1/ko not_active Ceased
- 2002-12-06 DE DE60228616T patent/DE60228616D1/de not_active Expired - Lifetime
- 2002-12-06 PL PL02369411A patent/PL369411A1/xx not_active Application Discontinuation
- 2002-12-06 IL IL16215002A patent/IL162150A0/xx unknown
- 2002-12-06 PT PT02783305T patent/PT1455781E/pt unknown
- 2002-12-06 BR BR0214798-0A patent/BR0214798A/pt not_active Application Discontinuation
- 2002-12-06 EP EP08162209A patent/EP1997492A1/en not_active Withdrawn
- 2002-12-06 WO PCT/GB2002/005554 patent/WO2003053438A1/en not_active Ceased
- 2002-12-06 US US10/498,444 patent/US20050165081A1/en not_active Abandoned
- 2002-12-06 DK DK02783305T patent/DK1455781T3/da active
- 2002-12-06 SI SI200230746T patent/SI1455781T1/sl unknown
- 2002-12-06 MX MXPA04005394A patent/MXPA04005394A/es active IP Right Grant
- 2002-12-06 EP EP02783305A patent/EP1455781B1/en not_active Revoked
2004
- 2004-05-31 ZA ZA2004/04260A patent/ZA200404260B/en unknown
- 2004-06-04 IS IS7300A patent/IS7300A/is unknown
- 2004-07-08 CO CO04064979A patent/CO5590926A2/es not_active Application Discontinuation
- 2004-07-09 NO NO20042912A patent/NO20042912L/no not_active Application Discontinuation
2008
- 2008-10-29 CY CY20081101221T patent/CY1108462T1/el unknown
2010
- 2010-09-06 JP JP2010199008A patent/JP2011016828A/ja active Pending

Also Published As

Publication number	Publication date
JP5335173B2 (ja)	2013-11-06
EP1455781A1 (en)	2004-09-15
JP2005516021A (ja)	2005-06-02
HUP0402023A2 (hu)	2005-01-28
JP2011016828A (ja)	2011-01-27
WO2003053438A1 (en)	2003-07-03
ES2303811T3 (es)	2009-02-01
DK1455781T3 (da)	2008-11-24
EP1455781B1 (en)	2008-08-27
NO20042912L (no)	2004-08-25
HK1069335A1 (en)	2005-05-20
ATE406160T1 (de)	2008-09-15
CN1630519A (zh)	2005-06-22
CA2468965A1 (en)	2003-07-03
PT1455781E (pt)	2008-11-03
MXPA04005394A (es)	2005-04-19
ZA200404260B (en)	2005-10-26
AU2002347371A1 (en)	2003-07-09
KR20040066886A (ko)	2004-07-27
CO5590926A2 (es)	2005-12-30
CY1108462T1 (el)	2014-04-09
SI1455781T1 (sl)	2008-12-31
US20050165081A1 (en)	2005-07-28
CN100408036C (zh)	2008-08-06
RU2320339C2 (ru)	2008-03-27
BR0214798A (pt)	2004-10-19
NZ533106A (en)	2008-02-29
PL369411A1 (en)	2005-04-18
EP1997492A1 (en)	2008-12-03
DE60228616D1 (de)	2008-10-09
KR100858946B1 (ko)	2008-09-17
HUP0402023A3 (en)	2008-08-28
UA79443C2 (en)	2007-06-25
ES2303811T1 (es)	2008-09-01
RU2004121162A (ru)	2005-05-20
AU2002347371B2 (en)	2007-05-10
IL162150A0 (en)	2005-11-20
CA2468965C (en)	2011-08-30
GB0129457D0 (en)	2002-01-30

Publication	Publication Date	Title
CY1108462T1 (el)	2014-04-09	Χρηση της αναστροζολης για τη θεραπευτικη αντιμετωπιση μετεμμηνοπαυσιακων γυναικων με καρκινο του μαστου σε πρωιμο σταδιο
MY127290A (en)	2006-11-30	New use of flibanserin
MXPA03011941A (es)	2004-03-26	Ligandos del receptor de 5-ht y sus usos.
EA200101046A1 (ru)	2002-04-25	Производные индигоидных бис-индолов
IL159859A (en)	2009-12-24	Antineoplastic combinations
PL1830876T3 (pl)	2015-09-30	Zastosowanie imikwimodu do leczenia przerzutów do skóry wywodzących się od guza stanowiącego raka piersi
DK1482948T3 (da)	2006-11-27	Kontinuerlig sulfataseinhiberende progestogen-hormonsubstitutionsbehandling
MXPA04003087A (es)	2004-09-06	Derivados de cromano como ligados de 5-hidroxitriptamina-6.
GR970100409A (el)	1998-06-30	Βελτιωσεις στην προληψη του καρκινου του μαστου και σε σχεση με αυτην
MXPA05006981A (es)	2005-12-14	Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
EA200200943A1 (ru)	2003-02-27	Гормональная терапия рака молочной железы
WO2002020000A3 (en)	2003-02-27	Combined estrogen blockade of the breast with exemestane and raloxifene
CA2481602A1 (en)	2003-10-23	Pharmaceutical composition comprising arsenite for the treatment of malignancy
GB0208785D0 (en)	2002-05-29	Treatment methtods
IL160382A0 (en)	2004-07-25	Use of 4-pyridylmethylphthalazines for cancer treatment
IL143988A0 (en)	2002-04-21	Compositions and methods for intraductal gene therapy
DK1326617T3 (da)	2006-12-18	Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeom
YU29903A (sh)	2006-08-17	Upotreba antiprogestina za indukciju apoptoze u ćeliji
ATE252896T1 (de)	2003-11-15	Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs
EP1025098A4 (en)	2003-03-05	BENTZOTHIOPHENE
WO2003035104A3 (en)	2003-12-11	Compositions and methods for selected tumor treatment
TW200605891A (en)	2006-02-16	Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
PL1732574T3 (pl)	2010-07-30	Zastosowanie o-ATP do leczenia chorób związanych z angiogenezą
MXPA04002407A (es)	2004-05-31	Uso de 4-piridilmeetil-ftalazinas para el tratamiento de cancer.
UA51221A (uk)	2002-11-15	Спосіб лікування рецидивів раку шийки матки